Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Jianpixiaozhong particles and Wuse Dietotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Idiopathic Membranous Nephropathy
1 trial -
KL003 Cell Injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Sickle Cell Disease
1 trial -
KL003 cell injection Drug Product
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Transfusion-dependent Beta-Thalassemia
1 trial -
Ketogenic diet
United Therapeutics Europe Ltd
Heart Failure With Preserved Ejection Fraction
1 trial -
Ketone ester
COGNITION THERAPEUTICS INC
Hypoxia
2 trials -
Kuvan
BioMarin Pharmaceutical Australia Pty Ltd
Heart Failure
1 trial -
LCAR- F33S cells intravenous infusion
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Relapsed/Refractory Multiple Myeloma(MM)
1 trial -
LCAR-M61S cells preparation
Nanjing Legend Biotech Co.
Relapsed/Refractory Multiple Myeloma
1 trial -
LOC387715/HTRA1 genotyping
Hospital Authority, Hong Kong
Age-Related Macular Degeneration
1 trial -
Lactated ringers solution
The First People's Hospital of Lianyungang
Pancreatitis, Chronic
1 trial -
Lactobacillus rhamnosus F-1
Biotech Pharmaceutical Co.,
Allergic Rhinitis
1 trial -
Latanoprost
The First People's Hospital of Lianyungang
Ocular Hypertension
1 trial -
Learning with 3D-MR visualization models
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Teaching Innovation
1 trial -
Letrozole
The First People's Hospital of Lianyungang
Intrauterine Insemination
1 trial -
Letrozole
International Peace Maternity and Child Health Hospital
Letrozole
1 trial -
Lidocaine Hydrochloride 2% Injection Solution
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Colorectal Cancer
1 trial -
Lidocaine IV
Samsung Bioepis NL B.V.
Colorectal Cancer
1 trial -
Linaclotide
Second Affiliated Hospital of Xi'an Jiaotong University
Bowel Preparation
1 trial -
Lipid-based nutrient supplement
United Therapeutics Europe Ltd
Malnutrition
1 trial -
Liquid Biopsy (SPOT-MAS Assay)
Hospital Authority, Hong Kong
Lung Cancer
1 trial -
Liquid Biopsy Early Screening
The First People's Hospital of Lianyungang
Liquid Biopsy for Early Screening of Lung Cancer
1 trial -
LiveSpo Navax
Hospital Authority, Hong Kong
Acute Respiratory Tract Infections
1 trial -
Low dose Radiotherapy
United Therapeutics Europe Ltd
Covid19
1 trial -
Low dose midazolam
Hospital Authority, Hong Kong
Intubation
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources